Oscar Health (NYSE:OSCR) Director Mario Schlosser Sells 31,422 Shares

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 31,422 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the transaction, the director directly owned 449,444 shares in the company, valued at approximately $14,135,013.80. The trade was a 6.53% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The stock was sold at an average price of $30.79, for a total value of $4,618,500.00.
• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $25,854,400.00.

Oscar Health Trading Up 2.0%

Shares of Oscar Health stock opened at $32.90 on Wednesday. The stock has a fifty day simple moving average of $30.58 and a 200 day simple moving average of $23.01. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.55. The company has a market capitalization of $10.15 billion, a P/E ratio of 23.50, a price-to-earnings-growth ratio of 0.66 and a beta of 2.37. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business’s revenue was up 70.4% on a year-over-year basis. During the same period last year, the business earned ($0.89) EPS. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. CoreCap Advisors LLC boosted its stake in Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after acquiring an additional 1,000 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Oscar Health by 32.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after acquiring an additional 357 shares during the period. Quarry LP increased its stake in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after purchasing an additional 1,469 shares during the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of Oscar Health during the 2nd quarter worth approximately $57,000. Finally, Allworth Financial LP raised its holdings in shares of Oscar Health by 124.9% in the 2nd quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock worth $58,000 after purchasing an additional 1,128 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health News Summary

Here are the key news stories impacting Oscar Health this week:

• Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
• Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
• Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Barclays raised their price target on shares of Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Weiss Ratings raised shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Wells Fargo & Company increased their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research report on Friday, August 7th. Finally, UBS Group boosted their target price on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, Oscar Health currently has an average rating of “Hold” and an average price target of $26.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.